Mynd life sciences announces strategic debt reduction and new board member appointment

Vancouver, british columbia--(newsfile corp. - november 22, 2024) - mynd life sciences (cse: mynd) (otcqb: myndf) ("mynd" or the "company"), a leader in mental health diagnostics and treatments, today announced two significant strategic decisions aimed at strengthening the company's financial position and governance. these moves demonstrate a strong commitment to the company's vision and strategic plan to commercialize a diagnostic biomarker test for depression which is being initially developed for the purpose of diagnosing and monitoring those with major depressive disorder (mdd).
MYND Ratings Summary
MYND Quant Ranking